Fishing for synucleinopathy models

키워드

참고문헌 (252)

1. Abeliovich A, "Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system", Neuron, 25, pp.239~252 (2000)
2. Adams-Carr KL, "Constipation preceding Parkinson’s disease : a systematic review and meta-analysis", J Neurol Neurosurg Psychiatry, 87, pp.710~716 (2016)
3. Ahmad M, "Gamma-synuclein and the progression of cancer", FASEB J, 21, pp.3419~3430 (2007)
4. Aleström P, "Zebrafish : housing and husbandry recommendations", Lab Anim, 54, pp.213~224 (2020)
5. Allison JR, "A relationship between the transient structure in the monomeric state and the aggregation propensities of α-synuclein and β-synuclein", Biochemistry, 53, pp.7170~7183 (2014)
6. Altschul SF, "Basic local alignment search tool", J Mol Biol, 215, pp.403~410 (1990)
7. Anderson JP, "Phosphorylation of Ser-129 is the dominant pathological modification of alpha-synuclein in familial and sporadic Lewy body disease", J Biol Chem, 281, pp.29739~29752 (2006)
8. Appel-Cresswell S, "Alpha-synuclein p. H50Q, a novel pathogenic mutation for Parkinson’s disease", Mov Disord, 28, pp.811~813 (2013)
9. Asakawa K, "The Tol2-mediated Gal4-UAS method for gene and enhancer trapping in zebrafish", Methods, 49, pp.275~281 (2009)
10. Bai Q, "Zebrafish models of Tauopathy", Biochim Biophys Acta, 1812, pp.353~363 (2011)
11. Baker PA, "Immunohistochemical and ultrastructural analysis of the maturing larval zebrafish enteric nervous system reveals the formation of a neuropil pattern", Sci Rep, 9, pp.6941~ (2019)
12. Barbazuk WB, "The syntenic relationship of the zebrafish and human genomes", Genome Res, 10, pp.1351~1358 (2000)
13. Barbereau C, "Zebrafish models to study new pathways in tauopathies", Int J Mol Sci, 22, pp.4626~ (2021)
14. Barnhill LM, "Studying the pathophysiology of Parkinson’s disease using zebrafish", Biomedicines, 8, pp.197~ (2020)
15. Beach TG, "Vagus nerve and stomach synucleinopathy in Parkinson’s disease, incidental Lewy body disease, and normal elderly subjects : evidence against the"body-first"hypothesis", J Parkinsons Dis, 11, pp.1833~1843 (2021)
16. Bedell VM, "Lessons from morpholino-based screening in zebrafish", Brief Funct Genomics, 10, pp.181~188 (2011)
17. Bendor JT, "The function of α-synuclein", Neuron, 79, pp.1044~1066 (2013)
18. Benner EJ, "Nitrated α–synuclein immunity accelerates degeneration of nigral dopaminergic neurons", PLOS ONE, 3, pp.e1376~ (2008)
19. Bernis ME, "Prion-like propagation of human brain-derived alpha-synuclein in transgenic mice expressing human wild-type alpha-synuclein", Acta Neuropathol Commun, 3, pp.75~ (2015)
20. Bertotto LB, "Exploring interactions between xenobiotics, microbiota, and neurotoxicity in zebrafish", Neurotoxicology, 76, pp.235~244 (2020)
21. Beyer K, "α-Synuclein structure, posttranslational modification and alternative splicing as aggregation enhancers", Acta Neuropathol, 112, pp.237~251 (2006)
22. Beyer K, "Alpha-and beta-synuclein expression in Parkinson disease with and without dementia", J Neurol Sci, 310, pp.112~117 (2011)
23. Bill BR, "A primer for morpholino use in zebrafish", Zebrafish, 6, pp.69~77 (2009)
24. Blader P, "Zebrafish developmental genetics and central nervous system development", Hum Mol Genet, 9, pp.945~951 (2000)
25. Bonini NM, "Snaring the function of α-synuclein", Cell, 123, pp.359~361 (2005)
26. Borghammer P, "Neuropathological evidence of body-first vs. brain-first Lewy body disease", Neurobiol Dis, 161, pp.105557~ (2021)
27. Borrelli L, "Probiotic modulation of the microbiota-gut-brain axis and behaviour in zebrafish", Sci Rep, 6, pp.30046~ (2016)
28. Braak H, "Pathoanatomy of Parkinson’s disease", J Neurol, 247, pp.II3~II10 (2000)
29. Braak H, "Idiopathic Parkinson’s disease : possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen", J Neural Transm, 110, pp.517~536 (2003)
30. Burré J, "Cell biology and pathophysiology of α-synuclein", Cold Spring Harb Perspect Med, 8, pp.a024091~ (2018)
31. Cansız D, "Caprylic acid ameliorates rotenone induced inflammation and oxidative stress in the gut-brain axis in Zebrafish", Mol Biol Rep, 48, pp.5259~5273 (2021)
32. Cantarero-Prieto D, "The economic cost of dementia : a systematic review", Dementia, 19, pp.2637~2657 (2020)
33. Cariulo C, "Phospho-S129 alpha-synuclein is present in human plasma but not in cerebrospinal fluid as determined by an ultrasensitive immunoassay", Front Neurosci, 13, pp.889~ (2019)
34. Chavarría C, "Oxidation and nitration of α-synuclein and their implications in neurodegenerative diseases", Arch Biochem Biophys, 533, pp.25~32 (2013)
35. Chen M, "Complex splicing and neural expression of duplicated tau genes in zebrafish embryos", J Alzheimers Dis, 18, pp.305~317 (2009)
36. Chen YC, "Recapitulation of zebrafish sncga expression pattern and labeling the habenular complex in transgenic zebrafish using green fluorescent protein reporter gene", Dev Dyn, 238, pp.746~754 (2009)
37. Cheng B, "Ketogenic diet protects dopaminergic neurons against 6-OHDA neurotoxicity via up-regulating glutathione in a rat model of Parkinson’s disease", Brain Res, 1286, pp.25~31 (2009)
38. pyrene exposure that is relevant to human health risk assessment, "Mutat Res Rev Mutat Res", 2015, 64~89
39. Choi TY, "Zebrafish as an animal model for biomedical research", Exp Mol Med, 53, pp.310~317 (2021)
40. Choong CJ, "Neuroprotection of α-synuclein under acute and chronic rotenone and maneb treatment is abolished by its familial Parkinson’s disease mutations A30P, A53T and E46K", Neurotoxicology, 32, pp.857~863 (2011)
41. Chou AP, "Ziram causes dopaminergic cell damage by inhibiting E1 ligase of the proteasome", J Biol Chem, 283, pp.34696~34703 (2008)
42. Chu Y, "Age-associated increases of alpha-synuclein in monkeys and humans are associated with nigrostriatal dopamine depletion : is this the target for Parkinson’s disease?", Neurobiol Dis, 25, pp.134~149 (2007)
43. Conforti L, "Wallerian degeneration : an emerging axon death pathway linking injury and disease", Nat Rev Neurosci, 15, pp.394~409 (2014)
44. Conway KA, "Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease", Nat Med, 4, pp.1318~1320 (1998)
45. Coon EA, "Synucleinopathies", Continuum(Minneap Minn), 26, pp.72~92 (2020)
46. Corey DR, "Morpholino antisense oligonucleotides : tools for investigating vertebrate development", Genome Biol, 2 (2001)
47. Cornet C, "Combining zebrafish and CRISPR", Cas9 : toward a more efficient drug discovery pipeline, 2018, pp.9, 703~
48. Cuomo M, "DNA methylation profiles of Tph1A and BDNF in gut and brain of L. Rhamnosus-treated zebrafish", Biomolecules, 11, pp.142~ (2021)
49. pyrene induces locomotor dysfunction and development of neurodegenerative phenotypes in zebrafish, "Neurosci Lett", 2020, 134646~
50. Dauer W, "Parkinson’s disease : mechanisms and models", Neuron, 39, pp.889~909 (2003)
51. Davis DJ, "Microbial modulation of behavior and stress responses in zebrafish larvae", Behav Brain Res, 311, pp.219~227 (2016)
52. de Abreu MS, "Modeling gut-brain interactions in zebrafish", Brain Res Bull, 148, pp.55~62 (2019)
53. Dehal P, "Two rounds of whole genome duplication in the ancestral vertebrate", PLOS Biol, 3, pp.e314~ (2005)
54. Dias V, "The role of oxidative stress in Parkinson’s disease", J Parkinsons Dis, 3, pp.461~491 (2013)
55. Dickson DW, "Multiple system atrophy : a sporadic synucleinopathy", Brain Pathol, 9, pp.721~732 (1999)
56. Ding Y, "Tau protein and zebrafish models for tau-induced neurodegeneration", J Alzheimers Dis, 69, pp.339~353 (2019)
57. Dodiya HB, "Chronic stress-induced gut dysfunction exacerbates Parkinson’s disease phenotype and pathology in a rotenone-induced mouse model of Parkinson’s disease", Neurobiol Dis, 135, pp.104352~ (2020)
58. Du Y, "Spatial and temporal distribution of dopaminergic neurons during development in zebrafish", Front Neuroanat, 10, pp.115~ (2016)
59. Dukes AA, "Live imaging of mitochondrial dynamics in CNS dopaminergic neurons in vivo demonstrates early reversal of mitochondrial transport following MPP+ exposure", Neurobiol Dis, 95, pp.238~249 (2016)
60. Elgar G, "Plenty more fish in the sea : comparative and functional genomics using teleost models", Brief Funct Genomic Proteomic, 3, pp.15~25 (2004)
61. Engelender S, "Synphilin-1 associates with α-synuclein and promotes the formation of cytosolic inclusions", Nat Genet, 22, pp.110~114 (1999)
62. Engelender S, "Organization of the human synphilin-1 gene, a candidate for Parkinson’s disease", Mamm Genome, 11, pp.763~766 (2000)
63. Engeszer RE, "Zebrafish in the wild : a review of natural history and new notes from the field", Zebrafish, 4, pp.21~40 (2007)
64. Fan Y, "β-Synuclein modulates α-synuclein neurotoxicity by reducing α-synuclein protein expression", Hum Mol Genet, 15, pp.3002~3011 (2006)
65. Flinn L, "Zebrafish as a new animal model for movement disorders", J Neurochem, 106, pp.1991~1997 (2008)
66. Fontana BD, "The developing utility of zebrafish models of neurological and neuropsychiatric disorders : a critical review", Exp Neurol, 299, pp.157~171 (2018)
67. Ganz J, "Gut feelings : studying enteric nervous system development, function, and disease in the zebrafish model system", Dev Dyn, 247, pp.268~278 (2018)
68. George JM, "The synucleins", Genome Biol, 3 (2001)
69. Godoy R, "Dopaminergic neurons regenerate following chemogenetic ablation in the olfactory bulb of adult Zebrafish(Danio rerio)", Sci Rep, 10, pp.12825~ (2020)
70. Goedert M, "Alpha-synuclein and neurodegenerative diseases", Nat Rev Neurosci, 2, pp.492~501 (2001)
71. Goedert M, "Basic neurochemistry", pp.829~843 (2012), Elsevier
72. Goedert M, "Like prions : the propagation of aggregated tau and α-synuclein in neurodegeneration", Brain, 140, pp.266~278 (2016)
73. Gorostidi A, "α-Synuclein levels in blood plasma from LRRK2 mutation carriers", PLOS ONE, 7, pp.e52312~ (2012)
74. Greggio E, "Leucine-rich repeat kinase 2 mutations and Parkinson’s disease : three questions", ASN Neuro, 1, pp.AN20090007~ (2009)
75. Gregory A, "PLA2G6-associated neurodegeneration" (2017), University of Washington
76. Haikal C, "Microbiome changes : an indicator of Parkinson’s disease?", Transl Neurodegener, 8, pp.38~ (2019)
77. Hashimoto M, "β-Synuclein inhibits α-synuclein aggregation : a possible role as an anti-parkinsonian factor", Neuron, 32, pp.213~223 (2001)
78. Hashimoto M, "β-Synuclein in the pathogenesis of Parkinson’s disease and related α-synucleinopathies : emerging roles and new directions", Future Neurol, 7, pp.155~163 (2012)
79. Hawkes CH, "Parkinson’s disease : a dual-hit hypothesis", Neuropathol Appl Neurobiol, 33, pp.599~614 (2007)
80. Hoenen C, "Alpha-synuclein proteins promote pro-inflammatory cascades in microglia : stronger effects of the A53T mutant", PLOS ONE, 11, pp.e0162717~ (2016)
81. Hoppe SO, "α-Synuclein strains : does amyloid conformation explain the heterogeneity of synucleinopathies?", Biomolecules, 11, pp.931~ (2021)
82. Houlden H, "The genetics and neuropathology of Parkinson’s disease", Acta Neuropathol, 124, pp.325~338 (2012)
83. Howe K, "The zebrafish reference genome sequence and its relationship to the human genome", Nature, 496(7446), pp.498~503 (2013)
84. Howe K, "Behavioral and neural genetics of zebrafish", pp.551~562 (2020), Academic Press
85. Hruska KS, "Gaucher disease : mutation and polymorphism spectrum in the glucocerebrosidase gene(GBA)", Hum Mutat, 29, pp.567~583 (2008)
86. Hu Q, "Effects of titanium dioxide nanoparticles exposure on Parkinsonism in zebrafish larvae and PC12", Chemosphere, 173, pp.373~379 (2017)
87. Ingelsson M, "Alpha-synuclein oligomers—neurotoxic molecules in Parkinson’s disease and other lewy body disorders", Front Neurosci, 10, pp.408~ (2016)
88. Inglis KJ, "Polo-like kinase 2(PLK2)phosphorylates α-synuclein at serine 129 in central nervous system", J Biol Chem, 284, pp.2598~2602 (2009)
89. Innos J, "Using rotenone to model Parkinson’s disease in mice : a review of the role of pharmacokinetics", Chem Res Toxicol, 34, pp.1223~1239 (2021)
90. Ishikawa-Ankerhold HC, "Advanced fluorescence microscopy techniques—FRAP, FLIP, FLAP, FRET and FLIM", Molecules, 17, pp.4047~4132 (2012)
91. Jakes R, "Identification of two distinct synucleins from human brain", FEBS Lett, 345, pp.27~32 (1994)
92. Jiang W, "Epigenetic upregulation of alpha-synuclein in the rats exposed to methamphetamine", Eur J Pharmacol, 745, pp.243~248 (2014)
93. Jo E, "alpha-Synuclein membrane interactions and lipid specificity", J Biol Chem, 275, pp.34328~34334 (2000)
94. Johnson ME, "An update on the rotenone models of Parkinson’s disease : their ability to reproduce the features of clinical disease and model gene–environment interactions", Neurotoxicology, 46, pp.101~116 (2015)
95. Johnson ME, "Rotenone induces gastrointestinal pathology and microbiota alterations in a rat model of Parkinson’s disease", Neurotoxicology, 65, pp.174~185 (2018)
96. Kalueff AV, "Zebrafish as an emerging model for studying complex brain disorders", Trends Pharmacol Sci, 35, pp.63~75 (2014)
97. Kaur G, "Dysregulation of the gut-brain axis, dysbiosis and influence of numerous factors on gut microbiota associated Parkinson’s disease", Curr Neuropharmacol, 19, pp.233~247 (2021)
98. Kaur U, "Membrane interactions of α-synuclein probed by neutrons and photons", Acc Chem Res, 54, pp.302~310 (2021)
99. Keatinge M, "Glucocerebrosidase 1 deficient Danio rerio mirror key pathological aspects of human Gaucher disease and provide evidence of early microglial activation preceding alpha-synuclein-independent neuronal cell death", Hum Mol Genet, 24, pp.6640~6652 (2015)
100. Keller JM, "Conn’s handbook of models for human aging", pp.351~359 (2018), Academic Press
101. Khotimah H, "Decreasing α-synuclein aggregation by methanolic extract of Centella asiatica in zebrafish Parkinson’s model", Asian Pac J Trop Biomed, 5, pp.948~954 (2015)
102. Khotimah H, "Zebrafish Parkinson’s model : rotenone decrease motility, dopamine, and increase α-synuclein aggregation and apoptosis of zebrafish brain", Int J Pharm Tech Res, 8, pp.614~621 (2015)
103. Kimmel CB, "Genetics and early development of zebrafish", Trends Genet, 5, pp.283~288 (1989)
104. Kimmel CB, "Patterning the brain of the zebrafish embryo", Annnu Rev Neurosci, 16, pp.707~732 (1993)
105. Kimmel CB, "Stages of embryonic development of the zebrafish", Dev Dyn, 203, pp.253~310 (1995)
106. Koppel N, "Chemical transformation of xenobiotics by the human gut microbiota", Science, 356, pp.eaag2770~ (2017)
107. Kostyuk AI, "In vivo imaging with genetically encoded redox biosensors", Int J Mol Sci, 21, pp.8164~ (2020)
108. Krüger R, "Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson’s disease", Nat Genet, 18, pp.106~108 (1998)
109. Kuil LE, "Zebrafish : a model organism for studying enteric nervous system development and disease", Front Cell Dev Biol, 8, pp.629073~ (2021)
110. Kumar A, "Peli1b governs the brain patterning via ERK signaling pathways in zebrafish embryos", Gene, 694, pp.1~6 (2019)
111. Kurian MA, "Phenotypic spectrum of neurodegeneration associated with mutations in the PLA2G6 gene(PLAN)", Neurology, 70, pp.1623~1629 (2008)
112. Lavedan C, "Identification, localization and characterization of the human γ-synuclein gene", Hum Genet, 103, pp.106~112 (1998)
113. Lee HJ, "Alpha-synuclein stimulation of astrocytes : potential role for neuroinflammation and neuroprotection", Oxid Med Cell Longev, 3, pp.283~287 (2010)
114. Lee JG, "Genetic approaches using zebrafish to study the microbiota–gut–brain axis in neurological disorders", Cells, 10, pp.566~ (2021)
115. Lee VMY, "Progress from Alzheimer’s tangles to pathological tau points towards more effective therapies now", J Alzheimers Dis, 9(3 Suppl), pp.257~262 (2006)
116. Lehtonen Š, "Dysfunction of cellular proteostasis in Parkinson’s disease", Front Neurosci, 13, pp.457~ (2019)
117. Lennaerts-Kats H, ""How long can I carry on?"The need for palliative care in Parkinson’s disease : a qualitative study from the perspective of bereaved family caregivers", J Parkinsons Dis, 10, pp.1631~1642 (2020)
118. Leong SL, "Modulation of alpha-synuclein aggregation by dopamine : a review", Neurochem Res, 34, pp.1838~1846 (2009)
119. Lesage S, "G51D α-synuclein mutation causes a novel parkinsonian–pyramidal syndrome", Ann Neurol, 73, pp.459~471 (2013)
120. Li J, "Conformational behavior of human α-synuclein is modulated by familial Parkinson’s disease point mutations A30P and A53T", Neurotoxicology, 23, pp.553~567 (2002)
121. Li N, "Immunoregulation of microglial polarization : an unrecognized physiological function of α-synuclein", J Neuroinflammation, 17, pp.272~ (2020)
122. Li X, "Developmental neurotoxicity fingerprint of silica nanoparticles at environmentally relevant level on larval zebrafish using a neurobehavioral-phenomics-based biological warning method", Sci Total Environ, 752, pp.141878~ (2021)
123. Lingor P, "Axonal degeneration as a therapeutic target in the CNS", Cell Tissue Res, 349, pp.289~311 (2012)
124. Linnertz C, "Genetic regulation of α-synuclein mRNA expression in various human brain tissues", PLOS ONE, 4, pp.e7480~ (2009)
125. Lionnet A, "Does Parkinson’s disease start in the gut?", Acta Neuropathol, 135, pp.1~12 (2018)
126. Liu J, "Synphilin-1 attenuates mutant LRRK2-induced neurodegeneration in Parkinson’s disease models", Hum Mol Genet, 25, pp.672~680 (2016)
127. Liu J, "Gut microbiota approach—a new strategy to treat Parkinson’s disease", Front Cell Infect Microbiol, 10, pp.570658~ (2020)
128. Lu J, "Profiling of gene duplication patterns of sequenced teleost genomes : evidence for rapid lineage-specific genome expansion mediated by recent tandem duplications", BMC Genomics, 13, pp.246~ (2012)
129. Luke GA, "Reporter gene assays: methods and protocols", pp.2018, Humana Press
130. Lulla A, "Neurotoxicity of the Parkinson disease-associated pesticide ziram is synuclein-dependent in zebrafish embryos", Environ Health Perspect, 124, pp.1766~1775 (2016)
131. Luo C, "α-Synuclein and tyrosine hydroxylase expression in acute rotenone toxicity", Int J Mol Med, 19, pp.517~521 (2007)
132. Lv DJ, "Sleep deprivation caused a memory defects and emotional changes in a rotenone-based zebrafish model of Parkinson’s disease", Behav Brain Res, 372, pp.112031~ (2019)
133. Ma PM, "Catecholaminergic systems in the zebrafish. IV. Organization and projection pattern of dopaminergic neurons in the diencephalon", J Comp Neurol, 460, pp.13~37 (2003)
134. Ma Q, "Impact of microbiota on central nervous system and neurological diseases : the gut-brain axis", J Neuroinflammation, 16, pp.53~ (2019)
135. Madden JC, "Strategies for the optimisation of in vivo experiments in accordance with the 3Rs philosophy", Regul Toxicol Pharmacol, 63, pp.140~154 (2012)
136. Makhija DT, "Studies on sensitivity of zebrafish as a model organism for Parkinson’s disease : comparison with rat model", J Pharmacol Pharmacother, 5, pp.39~46 (2014)
137. Maroteaux L, "Synuclein : a neuron-specific protein localized to the nucleus and presynaptic nerve terminal", J Neurosci, 8, pp.2804~2815 (1988)
138. Martins T, "Anaesthesia and analgesia in laboratory adult zebrafish : a question of refinement", Lab Anim, 50, pp.476~488 (2016)
139. Marx FP, "Identification and functional characterization of a novel R621C mutation in the synphilin-1 gene in Parkinson’s disease", Hum Mol Genet, 12, pp.1223~1231 (2003)
140. Matsui H, "Cerebrospinal fluid injection into adult zebrafish for disease research", J Neural Transm, 124, pp.1627~1633 (2017)
141. Matsui H, "An optimized method for counting dopaminergic neurons in zebrafish", PLOS ONE, 12, pp.e0184363~ (2017)
142. Maximino C, "Measuring anxiety in zebrafish : a critical review", Behav Brain Res, 214, pp.157~171 (2010)
143. Mbefo MK, "Phosphorylation of synucleins by members of the Polo-like kinase family", J Biol Chem, 285, pp.2807~2822 (2010)
144. Mehra S, "α-Synuclein misfolding and aggregation : implications in Parkinson’s disease pathogenesis", Biochim Biophys Acta Proteins Proteomics, 1867, pp.890~908 (2019)
145. Melki R, "Role of different alpha-synuclein strains in synucleinopathies, similarities with other neurodegenerative diseases", J Parkinsons Dis, 5, pp.217~227 (2015)
146. Milanese C, "Hypokinesia and reduced dopamine levels in zebrafish lacking β-and γ1-synucleins", J Biol Chem, 287, pp.2971~2983 (2012)
147. Milanese C, "Activation of the DNA damage response in vivo in synucleinopathy models of Parkinson’s disease", Cell Death Dis, 9, pp.818~ (2018)
148. Mohanta L, "Microbial communities modulating brain functioning and behaviors in zebrafish : a mechanistic approach", Microb Pathog, 145, pp.104251~ (2020)
149. Moulton JD, "Using morpholinos to control gene expression", Curr Protoc Nucleic Acid Chem, 68, pp.4.30.1~4.30.29 (2017)
150. Moussavi Nik SH, "Hypoxia alters expression of zebrafish microtubule-associated protein tau(mapta, maptb)gene transcripts", BMC Res Notes, 7, pp.767~ (2014)
151. Mudò G, "Transgenic expression and activation of PGC-1α protect dopaminergic neurons in the MPTP mouse model of Parkinson’s disease", Cell Mol Life Sci, 69, pp.1153~1165 (2012)
152. Musgrove REJ, "Neuroprotective upregulation of endogenous alpha-synuclein precedes ubiquitination in cultured dopaminergic neurons", Neurotox Res, 19, pp.592~602 (2011)
153. Musgrove RE, "The metabolomics of alpha-synuclein(SNCA)gene deletion and mutation in mouse brain", Metabolomics, 10, pp.114~122 (2014)
154. Najib NHM, "Modeling Parkinson’s disease in zebrafish", CNS Neurol Disord Drug Targets, 19, pp.386~399 (2020)
155. Ng CH, "Genetic or pharmacological activation of the Drosophila PGC-1α ortholog spargel rescues the disease phenotypes of genetic models of Parkinson’s disease", Neurobiol Aging, 55, pp.33~37 (2017)
156. Nietzel T, "The fluorescent protein sensor roGFP2-Orp1 monitors in vivo H2O2 and thiol redox integration and elucidates intracellular H2O2 dynamics during elicitor-induced oxidative burst in Arabidopsis", New Phytol, 221, pp.1649~1664 (2019)
157. "SNCA - synuclein alpha" (2017)[URL]
158. Northam C, "Metabolic regulation by the PGC-1α and PGC-1β coactivators in larval zebrafish(Danio rerio)", Comp Biochem Physiol A Mol Integr Physiol, 234, pp.60~67 (2019)
159. Nuytemans K, "Genetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes : a mutation update", Hum Mutat, 31, pp.763~780 (2010)
160. O’Donnell KC, "Axon degeneration and PGC-1α-mediated protection in a zebrafish model of α-synuclein toxicity", Dis Model Mech, 7, pp.571~582 (2014)
161. O’Hara DM, "LRRK2 and α-synuclein : distinct or synergistic players in Parkinson’s disease?", Front Neurosci, 14, pp.577~ (2020)
162. Ohnesorge N, "Current methods to investigate nociception and pain in zebrafish", Front Neurosci, 15, pp.632634~ (2021)
163. Ohno M, "The enteric nervous system in zebrafish larvae can regenerate via migration into the ablated area and proliferation of neural crest-derived cells", Development, 148, pp.dev195339~ (2021)
164. Olsson C, "Development of enteric and vagal innervation of the zebrafish(Danio rerio)gut", J Comp Neurol, 508, pp.756~770 (2008)
165. Ostrerova N, "α-Synuclein shares physical and functional homology with 14-3-3 proteins", J Neurosci, 19, pp.5782~5791 (1999)
166. Oueslati A, "Polo-like kinase 2 regulates selective autophagic α-synuclein clearance and suppresses its toxicity in vivo", Proc Natl Acad Sci USA, 110, pp.E3945~E3954 (2013)
167. Abid Oueslati, "Protein Transmission, Seeding and Degradation: Key Steps for α-Synuclein Prion-Like Propagation", Experimental Neurobiology, 23(4), pp.324~336 (2014), 한국뇌신경과학회
168. Parichy DM, "Normal table of postembryonic zebrafish development : staging by externally visible anatomy of the living fish", Dev Dyn, 238, pp.2975~3015 (2009)
169. Park JY, "β-Synuclein inhibits formation of α-synuclein protofibrils : a possible therapeutic strategy against Parkinson’s disease", Biochemistry, 42, pp.3696~3700 (2003)
170. Parkinson J, "An essay on the shaking palsy. 1817", J Neuropsychiatry Clin Neurosci, 14, pp.223~236 (2002)
171. Perez RG, "A role for alpha-synuclein in the regulation of dopamine biosynthesis", J Neurosci, 22, pp.3090~3099 (2002)
172. Periquet M, "Aggregated α-synuclein mediates dopaminergic neurotoxicity in vivo", J Neurosci, 27, pp.3338~3346 (2007)
173. Peters OM, "Gamma-synuclein pathology in amyotrophic lateral sclerosis", Ann Clin Transl Neurol, 2, pp.29~37 (2015)
174. Pham LN, "Methods for generating and colonizing gnotobiotic zebrafish", Nat Protoc, 3, pp.1862~1875 (2008)
175. Pietrucci D, "Can gut microbiota be a good predictor for Parkinson’s disease? A machine learning approach", Brain Sci, 10, pp.242~ (2020)
176. Piovesan A, "Human protein-coding genes and gene feature statistics in 2019", BMC Res Notes, 12, pp.315~ (2019)
177. Polymeropoulos MH, "Mutation in the alpha-synuclein gene identified in families with Parkinson’s disease", Science, 276, pp.2045~2047 (1997)
178. Prabhudesai S, "A novel"molecular tweezer"inhibitor of α-synuclein neurotoxicity in vitro and in vivo", Neurotherapeutics, 9, pp.464~476 (2012)
179. Prabhudesai S, "LRRK2 knockdown in zebrafish causes developmental defects, neuronal loss, and synuclein aggregation", J Neurosci Res, 94, pp.717~735 (2016)
180. Proukakis C, "A novel α-synuclein missense mutation in Parkinson disease", Neurology, 80, pp.1062~1064 (2013)
181. Provost E, "Viral 2A peptides allow expression of multiple proteins from a single ORF in transgenic zebrafish embryos", Genesis, 45, pp.625~629 (2007)
182. Punsoni M, "Enteric pathologic manifestations of alpha-synucleinopathies", Appl Immunohistochem Mol Morphol, 27, pp.543~548 (2019)
183. Quilty MC, "Alpha-synuclein is upregulated in neurones in response to chronic oxidative stress and is associated with neuroprotection", Exp Neurol, 199, pp.249~256 (2006)
184. Ravi V, "The divergent genomes of teleosts", Annnu Rev Anim Biosci, 6, pp.47~68 (2018)
185. Recchia A, "Alpha-synuclein and Parkinson’s disease", FASEB J, 18, pp.617~626 (2004)
186. Rey NL, "Review : spreading the word : precise animal models and validated methods are vital when evaluating prion-like behaviour of alpha-synuclein", Neuropathol Appl Neurobiol, 42, pp.51~76 (2016)
187. Rietdijk CD, "Exploring Braak’s Hypothesis of Parkinson’s disease", Front Neurol, 8, pp.37~ (2017)
188. Rodriguez L, "Import and export of misfolded α-synuclein", Front Neurosci, 12, pp.344~ (2018)
189. Rolig AS, "The enteric nervous system promotes intestinal health by constraining microbiota composition", PLOS Biol, 15, pp.e2000689~ (2017)
190. Rotshenker S, "Wallerian degeneration : the innate-immune response to traumatic nerve injury", J Neuroinflammation, 8, pp.109~ (2011)
191. Sager JJ, "Transgenic zebrafish models of neurodegenerative diseases", Brain Struct Funct, 214, pp.285~302 (2010)
192. Sampson TR, "Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson’s disease", Cell, 167, pp.1469~1480.e12 (2016)
193. Sánchez E, "Pla2g6 deficiency in zebrafish leads to dopaminergic cell death, axonal degeneration, increased beta-synuclein expression, and defects in brain functions and pathways", Mol Neurobiol, 55, pp.6734~6754 (2018)
194. Sargent D, "Investigating the neuroprotective effect of AAV-mediated β-synuclein overexpression in a transgenic model of synucleinopathy", Sci Rep, 8, pp.17563~ (2018)
195. Savica R, "When do α-synucleinopathies start? An epidemiological timeline: a review", JAMA Neurol, 75, pp.503~509 (2018)
196. Sen S, "The therapeutic potential of LRRK2 and α-synuclein in Parkinson’s disease", Antioxid Redox Signal, 11, pp.2167~2187 (2009)
197. Senior SL, "Increased striatal dopamine release and hyperdopaminergic-like behaviour in mice lacking both alpha-synuclein and gamma-synuclein", Eur J Neurosci, 27, pp.947~957 (2008)
198. Shaafi S, "The efficacy of the ketogenic diet on motor functions in Parkinson’s disease : a rat model", Iran J Neurol, 15, pp.63~69 (2016)
199. Shaltiel-Karyo R, "Inhibiting α-synuclein oligomerization by stable cell-penetrating β-synuclein fragments recovers phenotype of Parkinson’s disease model flies", PLOS ONE, 5, pp.e13863~ (2010)
200. Shen T, "The association between the gut microbiota and Parkinson’s disease, a meta-analysis", Front Aging Neurosci, 13, pp.636545~ (2021)
201. Shepherd I, "Development of the zebrafish enteric nervous system", Methods Cell Biol, 101, pp.143~160 (2011)
202. Shi L, "Pilot study : molecular risk factors for diagnosing sporadic Parkinson’s disease based on gene expression in blood in MPTP-induced rhesus monkeys", Oncotarget, 8, pp.105606~105614 (2017)
203. Shishido T, "Synphilin-1 has neuroprotective effects on MPP+-induced Parkinson’s disease model cells by inhibiting ROS production and apoptosis", Neurosci Lett, 690, pp.145~150 (2019)
204. Siddiqui IJ, "The Parkinson disease gene SNCA : evolutionary and structural insights with pathological implication", Sci Rep, 6, pp.24475~ (2016)
205. Slijkerman R, "Poor splice-site recognition in a humanized zebrafish knockin model for the recurrent deep-intronic c. 7595-2144A>G mutation in USH2A", Zebrafish, 15, pp.597~609 (2018)
206. Smith WW, "Synphilin-1 attenuates neuronal degeneration in the A53T alpha-synuclein transgenic mouse model", Hum Mol Genet, 19, pp.2087~2098 (2010)
207. Specht CG, "Deletion of the alpha-synuclein locus in a subpopulation of C57BL", 6J inbred mice, 2001, pp.2, 11~
208. Spillantini MG, "Assignment of human alpha-synuclein(SNCA)and beta-synuclein(SNCB)genes to chromosomes 4q21 and 5q35", Genomics, 27, pp.379~381 (1995)
209. Spillantini MG, "α-synuclein in Lewy bodies", Nature, 388, pp.839~840 (1997)
210. Stefanis L, "α-Synuclein in Parkinson’s disease", Cold Spring Harb Perspect Med, 2, pp.a009399~ (2012)
211. Stewart AM, "Zebrafish models for translational neuroscience research : from tank to bedside", Trends Neurosci, 37, pp.264~278 (2014)
212. Strähle U, "Zebrafish embryos as an alternative to animal experiments—a commentary on the definition of the onset of protected life stages in animal welfare regulations", Reprod Toxicol, 33, pp.128~132 (2012)
213. Sun Z, "Discovery and characterization of three novel synuclein genes in zebrafish", Dev Dyn, 237, pp.2490~2495 (2008)
214. Tagliaferro P, "Retrograde axonal degeneration in Parkinson disease", J Parkinsons Dis, 6, pp.1~15 (2016)
215. Tanaka M, "Aggresomes formed by α-synuclein and synphilin-1 are cytoprotective", J Biol Chem, 279, pp.4625~4631 (2004)
216. Tannenbaum J, "Russell and Burch’s 3Rs then and now : the need for clarity in definition and purpose", J Am Assoc Lab Anim Sci, 54, pp.120~132 (2015)
217. Tanner CM, "Rotenone, paraquat, and Parkinson’s disease", Environ Health Perspect, 119, pp.866~872 (2011)
218. Taymans JM, "Mechanisms in dominant parkinsonism : the toxic triangle of LRRK2, α-synuclein, and tau", BioEssays, 32, pp.227~235 (2010)
219. Thawkar BS, "Zebrafish as a promising tool for modeling neurotoxin-induced Alzheimer’s disease", Neurotox Res, 39, pp.949~965 (2021)
220. Toni M, "Fish synucleins : an update", Mar Drugs, 13, pp.6665~6686 (2015)
221. Touchman JW, "Human and mouse alpha-synuclein genes : comparative genomic sequence analysis and identification of a novel gene regulatory element", Genome Res, 11, pp.78~86 (2001)
222. Tyson T, "Sorting out release, uptake and processing of alpha-synuclein during prion-like spread of pathology", J Neurochem, 139, pp.275~289 (2016)
223. Uemura O, "Comparative functional genomics revealed conservation and diversification of three enhancers of the isl1 gene for motor and sensory neuron-specific expression", Dev Biol, 278, pp.587~606 (2005)
224. Ugalde CL, "Pathogenic mechanisms of prion protein, amyloid-β and α-synuclein misfolding : the prion concept and neurotoxicity of protein oligomers", J Neurochem, 139, pp.162~180 (2016)
225. Ünal İ, "Rotenone impairs oxidant", antioxidant balance both in brain and intestines in zebrafish, 2019, pp.129, 363~368
226. Usmani SM, "Molecular imaging: principles and practice Volume 2", pp.167~192 (2021), Academic Press
227. Vaccaro R, "Localization of α-synuclein in teleost central nervous system : immunohistochemical and Western blot evidence by 3D5 monoclonal antibody in the common carp, Cyprinus carpio", J Comp Neurol, 523, pp.1095~1124 (2015)
228. Van Den Berge N, "Animal models of brainfirst and body-first Parkinson’s disease", Neurobiol Dis, 163, pp.105599~ (2022)
229. van Ham TJ, "Intravital correlated microscopy reveals differential macrophage and microglial dynamics during resolution of neuroinflammation", Dis Models Mech, 7, pp.857~869 (2014)
230. Van Laar VS, "α-Synuclein amplifies cytoplasmic peroxide flux and oxidative stress provoked by mitochondrial inhibitors in CNS dopaminergic neurons in vivo", Redox Biol, 37, pp.101695~ (2020)
231. Varga M, "The doctor of delayed publications : the remarkable life of George Streisinger(1927–1984)", Zebrafish, 15, pp.314~319 (2018)
232. "bioRxiv", 2021
233. Hernández-Vargas RH, "Synphilin suppresses α-synuclein neurotoxicity in a Parkinson’s disease Drosophila model", Genesis, 49, pp.392~402 (2011)
234. Vascellari S, "Clinical phenotypes of Parkinson’s disease associate with distinct gut microbiota and metabolome enterotypes", Biomolecules, 11, pp.144~ (2021)
235. Vaz RL, "Zebrafish as an animal model for drug discovery in Parkinson’s disease and other movement disorders : a systematic review", Front Neurol, 9, pp.347~ (2018)
236. Visanji NP, "α-Synuclein-based animal models of Parkinson’s disease : challenges and opportunities in a new era", Trends Neurosci, 39, pp.750~762 (2016)
237. Volff JN, "Genome evolution and biodiversity in teleost fish", Heredity, 94, pp.280~294 (2005)
238. Wakabayashi K, "The Lewy body in Parkinson’s disease : molecules implicated in the formation and degradation of α-synuclein aggregates", Neuropathology, 27, pp.494~506 (2007)
239. Wang Y, "Parkinson’s disease-like motor and non-motor symptoms in rotenone-treated zebrafish", Neurotoxicology, 58, pp.103~109 (2017)
240. Wang YC, "Knockdown of α-synuclein in cerebral cortex improves neural behavior associated with apoptotic inhibition and neurotrophin expression in spinal cord transected rats", Apoptosis, 21, pp.404~420 (2016)
241. Weston LJ, "In vivo aggregation of presynaptic alpha-synuclein is not influenced by its phosphorylation at serine-129", Neurobiol Dis, 152, pp.105291~ (2021)
242. White RM, "Transparent adult zebrafish as a tool for in vivo transplantation analysis", Cell Stem Cell, 2, pp.183~189 (2008)
243. Wyatt C, "Methods for studying the zebrafish brain : past, present and future", Eur J Neurosci, 42, pp.1746~1763 (2015)
244. Xi Y, "Transgenic zebrafish expressing green fluorescent protein in dopaminergic neurons of the ventral diencephalon", Dev Dyn, 240, pp.2539~2547 (2011)
245. Xu Y, "Unraveling the role of hydrogen peroxide in α-synuclein aggregation using an ultrasensitive nanoplasmonic probe", Anal Chem, 87, pp.1968~1973 (2015)
246. Yang X, "Hypermethylation of the gene coding for PGC-1α in peripheral blood leukocytes of patients with Parkinson’s disease", Front Neurosci, 14, pp.97~ (2020)
247. Yurtsever İ, "Rifampicin decreases neuroinflammation to maintain mitochondrial function and calcium homeostasis in rotenone-treated zebrafish", Drug Chem Toxicol, pp.1~8 (2020)
248. Zarranz JJ, "The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia", Ann Neurol, 55, pp.164~173 (2004)
249. Zhang Z, "Melatonin regulates the neurotransmitter secretion disorder induced by caffeine through the microbiota-gut-brain axis in zebrafish(Danio rerio)", Front Cell Dev Biol, 9, pp.678190~ (2021)
250. Zheng B, "PGC-1α, a potential therapeutic target for early intervention in Parkinson’s disease", Sci Transl Med, 2, pp.52ra73~ (2010)
251. Zhu J, "Fenvalerate triggers Parkinson-like symptom during zebrafish development through initiation of autophagy and p38 MAPK", mTOR signaling pathway, 2020, pp.243, 125336~
252. Zou J, "An exploratory analysis of γ-synuclein expression in endometrioid endometrial cancer", BMJ Open, 2, pp.e000611~ (2012)

관련 논문AI추천